Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
16.67
-0.13 (-0.77%)
At close: May 26, 2026, 4:00 PM EDT
16.65
-0.02 (-0.12%)
After-hours: May 26, 2026, 7:51 PM EDT
Sarepta Therapeutics Stock Forecast
Stock Price Forecast
According to 24 analysts polled by S&P Global, Sarepta Therapeutics stock has a consensus rating of "Hold" and an average price target of $22. The average 1-year stock price forecast is 31.97% higher than the current stock price, while the lowest is $5.00 (-70.01%) and the highest is $38 (+127.95%).
Price Target: $22 (+31.97%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Sarepta Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 8 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 14 | 14 | 13 | 13 | 12 | 13 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Total | 26 | 26 | 25 | 25 | 25 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | +13.98% | May 19, 2026 |
| Evercore ISI | Evercore ISI | Hold Maintains $20 → $19 | Hold | Maintains | $20 → $19 | +13.98% | May 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $35 | Buy | Maintains | $35 | +109.96% | May 15, 2026 |
| Barclays | Barclays | Hold Reiterates $20 | Hold | Reiterates | $20 | +19.98% | May 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Sell Reiterates $5 | Sell | Reiterates | $5 | -70.01% | May 7, 2026 |
Financial Forecast
Revenue This Year
1.86B
from 2.20B
Decreased by -15.30%
Revenue Next Year
1.45B
from 1.86B
Decreased by -22.29%
EPS This Year
3.49
from -7.13
EPS Next Year
1.01
from 3.49
Decreased by -70.94%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.2B | 2.0B | ||||||
| Avg | 1.9B | 1.4B | ||||||
| Low | 1.7B | 863.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.8% | 5.5% | ||||||
| Avg | -15.3% | -22.3% | ||||||
| Low | -24.3% | -53.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5.94 | 3.19 | ||||||
| Avg | 3.49 | 1.01 | ||||||
| Low | 2.13 | -0.29 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | -8.4% | ||||||
| Avg | - | -70.9% | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.